(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital ...

The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.

The two founders will describe an ultrasound-activated reagent that creates microbubble jackhammers to break up specimens much faster and share wisdom from the perspectives of faculty entrepreneurs.

All the Latest Game Footage and Images from The Outlast Trials: Reagent Starter Pack Get ready with the Reagent Starter Pack, which includes exclusive items. Advertisement All the Latest Game ...

We wish to alert your readers to MIAPAR, the minimum information about a protein affinity reagent. This is a proposal developed within the community as an important first step in formalizing ...